Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shujun Fu

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Journal of Cancer|September 23, 2024
Filamentous Actin in the Nucleus in Triple-Negative Breast Cancer Stem Cells: A Key to Drug-Induced Nucleolar Stress and Stemness Inhibition?Xinyu Wang, Runhong Liu, Linli Zhou, et al.
Biomaterials Science|January 13, 2021
CD133 peptide-conjugated pyropheophorbide-a as a novel photosensitizer for targeted photodynamic therapy in colorectal cancer stem cellsShichao Yan, Da Tang, Zhangyong Hong, et al.
Cell Reports|August 1, 2019
Glutamine Synthetase Promotes Radiation Resistance via Facilitating Nucleotide Metabolism and Subsequent DNA Damage RepairShujun Fu, Zhi Li, Lanbo Xiao, et al.
Frontiers in Oncology|March 14, 2022
Co-Expression and Combined Prognostic Value of CSPG4 and PDL1 in <i>TP53</i>-Aberrant Triple-Negative Breast CancerZhe-Yu Hu, Chanjuan Zheng, Jianbo Yang, et al.
The Journal of Gene Medicine|December 12, 2023
Amino acids and their roles in tumor immunotherapy of breast cancerHongzhuo Xia, Jianyu Zhu, Zhuomeng Zheng, et al.
International Journal of Radiation Oncology, Biology, Physics|December 22, 2021
Low Expression of ECT2 Confers Radiation Therapy Resistance Through Transcription Coupled Nucleolar DNA Damage RepairYanfang Qiu, Wenfeng Hu, Ming Wen, et al.
International Journal of Biological Sciences|April 15, 2024
Dysregulated Ribosome Biogenesis Is a Targetable Vulnerability in Triple-Negative Breast Cancer: MRPS27 as a Key Mediator of the Stemness-inhibitory Effect of LovastatinChanjuan Zheng, Hui Yao, Lu Lu, et al.
Clinical Pharmacology and Therapeutics|March 20, 2025
ICH M12 Drug Interaction Studies: Summary of the Efforts to Achieve Global ConvergenceKellie Reynolds, Xinning Yang, Sheila Annie Peters, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Journal of Cancer|September 23, 2024
Filamentous Actin in the Nucleus in Triple-Negative Breast Cancer Stem Cells: A Key to Drug-Induced Nucleolar Stress and Stemness Inhibition?Xinyu Wang, Runhong Liu, Linli Zhou, et al.
Biomaterials Science|January 13, 2021
CD133 peptide-conjugated pyropheophorbide-a as a novel photosensitizer for targeted photodynamic therapy in colorectal cancer stem cellsShichao Yan, Da Tang, Zhangyong Hong, et al.
Cell Reports|August 1, 2019
Glutamine Synthetase Promotes Radiation Resistance via Facilitating Nucleotide Metabolism and Subsequent DNA Damage RepairShujun Fu, Zhi Li, Lanbo Xiao, et al.
Frontiers in Oncology|March 14, 2022
Co-Expression and Combined Prognostic Value of CSPG4 and PDL1 in <i>TP53</i>-Aberrant Triple-Negative Breast CancerZhe-Yu Hu, Chanjuan Zheng, Jianbo Yang, et al.
The Journal of Gene Medicine|December 12, 2023
Amino acids and their roles in tumor immunotherapy of breast cancerHongzhuo Xia, Jianyu Zhu, Zhuomeng Zheng, et al.
International Journal of Radiation Oncology, Biology, Physics|December 22, 2021
Low Expression of ECT2 Confers Radiation Therapy Resistance Through Transcription Coupled Nucleolar DNA Damage RepairYanfang Qiu, Wenfeng Hu, Ming Wen, et al.
International Journal of Biological Sciences|April 15, 2024
Dysregulated Ribosome Biogenesis Is a Targetable Vulnerability in Triple-Negative Breast Cancer: MRPS27 as a Key Mediator of the Stemness-inhibitory Effect of LovastatinChanjuan Zheng, Hui Yao, Lu Lu, et al.
Clinical Pharmacology and Therapeutics|March 20, 2025
ICH M12 Drug Interaction Studies: Summary of the Efforts to Achieve Global ConvergenceKellie Reynolds, Xinning Yang, Sheila Annie Peters, et al.
Pageof 7